A detailed history of Northwest Bancshares, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Northwest Bancshares, Inc. holds 7,225 shares of ABT stock, worth $822,999. This represents 0.14% of its overall portfolio holdings.

Number of Shares
7,225
Previous 7,525 3.99%
Holding current value
$822,999
Previous $781,000 5.38%
% of portfolio
0.14%
Previous 0.13%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$100.07 - $118.13 $30,020 - $35,439
-300 Reduced 3.99%
7,225 $823,000
Q2 2024

Aug 08, 2024

SELL
$100.73 - $112.44 $40,292 - $44,976
-400 Reduced 5.05%
7,525 $781,000
Q1 2024

Apr 26, 2024

SELL
$109.52 - $120.96 $4,928 - $5,443
-45 Reduced 0.56%
7,925 $900,000
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $27,147 - $33,230
-301 Reduced 3.64%
7,970 $877,000
Q3 2023

Oct 27, 2023

BUY
$95.53 - $114.62 $50,630 - $60,748
530 Added 6.85%
8,271 $801,000
Q2 2023

Jul 24, 2023

BUY
$100.78 - $112.29 $10,985 - $12,239
109 Added 1.43%
7,741 $843,000
Q3 2022

Nov 15, 2022

SELL
$96.76 - $112.03 $9,676 - $11,203
-100 Reduced 1.29%
7,632 $738,000
Q2 2022

Aug 16, 2022

SELL
$102.07 - $123.37 $1,939 - $2,344
-19 Reduced 0.25%
7,732 $840,000
Q4 2021

Feb 09, 2022

SELL
$115.53 - $141.46 $808 - $990
-7 Reduced 0.09%
7,751 $1.09 Million
Q3 2021

Oct 13, 2021

BUY
$116.66 - $129.06 $12,715 - $14,067
109 Added 1.43%
7,758 $916,000
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $21,052 - $24,781
-199 Reduced 2.54%
7,649 $887,000
Q1 2021

Apr 23, 2021

BUY
$108.84 - $128.23 $43,971 - $51,804
404 Added 5.43%
7,848 $941,000
Q4 2020

Feb 05, 2021

SELL
$105.0 - $114.42 $21,000 - $22,884
-200 Reduced 2.62%
7,444 $815,000
Q2 2020

Aug 07, 2020

BUY
$76.57 - $98.0 $74,808 - $95,746
977 Added 14.65%
7,644 $698,000
Q1 2020

May 05, 2020

SELL
$62.82 - $91.86 $6,282 - $9,186
-100 Reduced 1.48%
6,667 $526,000
Q4 2019

Feb 10, 2020

SELL
$78.51 - $87.4 $10,598 - $11,799
-135 Reduced 1.96%
6,767 $588,000
Q3 2019

Oct 09, 2019

SELL
$81.84 - $88.74 $16,368 - $17,748
-200 Reduced 2.82%
6,902 $577,000
Q2 2019

Jul 17, 2019

BUY
$72.88 - $85.0 $30,390 - $35,445
417 Added 6.24%
7,102 $597,000
Q4 2018

Feb 08, 2019

SELL
$65.56 - $74.27 $45,892 - $51,989
-700 Reduced 9.48%
6,685 $484,000
Q3 2018

Oct 02, 2018

BUY
$60.81 - $73.36 $12,162 - $14,672
200 Added 2.78%
7,385 $542,000
Q2 2018

Aug 09, 2018

SELL
$57.57 - $63.54 $27,921 - $30,816
-485 Reduced 6.32%
7,185 $438,000
Q1 2018

May 09, 2018

SELL
$56.27 - $63.62 $3,376 - $3,817
-60 Reduced 0.78%
7,670 $460,000
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $414,946 - $444,243
7,730
7,730 $441,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Northwest Bancshares, Inc. Portfolio

Follow Northwest Bancshares, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Bancshares, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northwest Bancshares, Inc. with notifications on news.